# Axcelis Technologies Inc: Form 10-Q for the period ended Sep 30, 2011

- Company: [Axcelis Technologies Inc](/companies/acls.md) (CIK 1113232)
- Form: 10-Q
- Filed: 2011-11-04
- Accepted by EDGAR: Nov 4, 2011, 12:57 ET
- Period: 2011-09-30
- Accession: 0001104659-11-061003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1113232/000110465911061003/a11-25105_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1113232/000110465911061003/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-07-01 to 2011-09-30 | $72.5m | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2011-01-01 to 2011-09-30 | $259.0m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2011-07-01 to 2011-09-30 | $45.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2011-01-01 to 2011-09-30 | $166.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2011-07-01 to 2011-09-30 | $26.9m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2011-01-01 to 2011-09-30 | $92.1m | us-gaap:GrossProfit |
| Research and development | 3 months, 2011-07-01 to 2011-09-30 | $11.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2011-01-01 to 2011-09-30 | $35.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2011-07-01 to 2011-09-30 | −$189.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2011-01-01 to 2011-09-30 | $8.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2011-07-01 to 2011-09-30 | $230.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2011-01-01 to 2011-09-30 | $1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-07-01 to 2011-09-30 | $1.2m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months, 2011-01-01 to 2011-09-30 | $7.2m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2011-07-01 to 2011-09-30 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2011-01-01 to 2011-09-30 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-07-01 to 2011-09-30 | $0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2011-01-01 to 2011-09-30 | $0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2011-07-01 to 2011-09-30 | 108,192,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2011-01-01 to 2011-09-30 | 109,452,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2011-01-01 to 2011-09-30 | $852.0k | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2011-01-01 to 2011-09-30 | $1.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2011-09-30 | $44.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-09-30 | $215.6m | us-gaap:AssetsCurrent |
| Total assets | at 2011-09-30 | $272.7m | us-gaap:Assets |
| Current liabilities | at 2011-09-30 | $49.6m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2011-09-30 | $215.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 18,805 characters.

Certain statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Form 10-Q are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. The forward-looking statements contained herein are based on current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Factors that might cause such a difference include, among other things, those set forth or referred to under “Liquidity and Capital Resources” and “Risk Factors” and others discussed elsewhere in this Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.

### Overview

The semiconductor capital equipment industry is subject to significant cyclical swings in capital spending by semiconductor manufacturers. Capital spending is influenced by demand for semiconductors and the products using them, the utilization rate and capacity of existing semiconductor manufacturing facilities and changes in semiconductor technology, all of which are outside of our control. As a result, our revenue and gross margins fluctuate from year to year and period to period. We typically become more efficient in manufacturing products as they mature. Our operating expense base is largely fixed and does not vary significantly with changes in volume. Therefore, we experience fluctuations in operating results and cash flows depending on our revenue as driven by the level of capital expenditures by semiconductor manufacturers.

The sizable expense of building, upgrading or expanding a semiconductor fabrication facility is increasingly causing semiconductor companies to contract with foundries to manufacture their semiconductors. In addition, consolidation and partnering within the semiconductor manufacturing industry is increasing. We expect these trends to continue to reduce the number of our potential customers. This growing concentration of Axcelis’ customers may increase pricing pressure as higher percentages of our total revenue are tied to the buying decisions of a particular customer or a small number of customers.

During the three month period ending September 30, 2011, deterioration within the industry environment has decreased our revenues as compared with the prior quarter. Although future market conditions are difficult to predict, we expect revenue to continue to decline in the quarter ending December 31, 2011. Prior to these changing dynamics, during 2010, the market for our products steadily improved and we gained market share with our single wafer ion implant systems for high current and high energy applications (the Optima HDx and Optima XEx). In 2011, we continue to penetrate new customers with our Optima implant products, which we expect will lead to additional future sales. We expect to gain market share in 2011 with our Integra dry strip products. In the event that the industry conditions cause the demand for Axcelis’ products to decline in future periods, we believe we can align manufacturing and operating expense levels to the changing business conditions and provide sufficient liquidity to support operations.

Operating results for the periods presented are not necessarily indicative of the results that may be expected for future interim periods or years as a whole.

### Critical Accounting Estimates

Management’s discussion and analysis of our financial condition and results of operations are based upon Axcelis’ consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on- going basis, we evaluate our estimates, including those related to revenue recognition, income taxes, accounts receivable, inventory and warranty obligations. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

There has been no material change in the nature of our critical accounting estimates and judgments as described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2010.

### Results of Operations

The following table sets forth our results of operations as a percentage of revenue for the periods indicated:

### Axcelis Technologies, Inc.

### Consolidated Statements of Operations

### Percentage of Revenue

### (Unaudited)

| Revenue | Three months ended September 30, 2011 | 2010 | Nine months ended September 30, 2011 | 2010 |
| --- | ---: | ---: | ---: | ---: |
| Product | 88.8% | 88.1% | 90.8% | 86.4% |
| Service | 11.2 | 11.9 | 9.2 | 13.6 |
| Total revenue | 100.0 | 100.0 | 100.0 | 100.0 |
| Cost of revenue |  |  |  |  |
| Product | 55.3 | 63.7 | 57.8 | 61.5 |
| Service | 7.6 | 7.7 | 6.6 | 8.6 |
| Total cost of revenue | 62.9 | 71.4 | 64.4 | 70.1 |
| Gross profit | 37.1 | 28.6 | 35.6 | 29.9 |
| Operating expenses |  |  |  |  |
| Research and development | 15.7 | 13.2 | 13.5 | 15.6 |
| Sales and marketing | 10.0 | 9.5 | 8.8 | 11.2 |
| General and administrative | 11.7 | 10.5 | 10.0 | 12.7 |
| Total operating expenses | 37.4 | 33.2 | 32.3 | 39.5 |
| Income (loss) from operations | (0.3) | (4.6) | 3.3 | (9.6) |
| Other income (expense) |  |  |  |  |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 |
| Other, net | 2.2 | (2.6) | 0.0 | (1.1) |
| Total other income (expense) | 2.2 | (2.6) | 0.0 | (1.1) |
| Income (loss) before income taxes | 1.9 | (7.2) | 3.3 | (10.7) |
| Income taxes | 0.3 | 1.2 | 0.5 | 1.3 |
| Net income (loss) | 1.6% | (8.4)% | 2.8% | (12.0)% |

13

### Three and nine months ended September 30, 2011 in comparison to the three and nine months ended September 30, 2010

### Revenue

#### Product

Product revenue, which includes systems sales, sales of spare parts and product upgrades, was $64.4 million, or 88.8% of revenue, for the three months ended September 30, 2011, compared with $66.2 million, or 88.1% of revenue for the three months ended September 30, 2010. Product revenue was $235.3 million, or 90.8% of revenue for the nine months ended September 30, 2011, compared with $157.1 million, or 86.4% of revenue for the nine months ended September 30, 2010. System sales were $35.1 million, or 48.5% of revenue, for the three months ended September 30, 2011, compared with $39.1 million, or 52.1% of revenue, for the three months ended September 30, 2010. System sales were $143.7 million, or 55.5% of revenue, for the nine months ended September 30, 2011, compared with $77.3 million, or 42.5% of revenue, for the nine months ended September 30, 2010. The decrease in product revenue in the three month period ended September 30, 2011 is attributable to the weakening of the semiconductor market and a related delay in capital spending by semiconductor manufacturers, following stronger quarters at the beginning of 2011, as reflected in the nine-month year over year comparisons. Despite this market slowdown, we believe we are gaining traction with our single wafer ion implant systems and with our dry strip products.

A portion of our revenue from system sales is deferred until installation and other services related to future deliverables are performed. The total amount of deferred revenue at September 30, 2011 and 2010 was $11.9 million and $11.5 million, respectively. The slight increase was mainly due to the increase in systems sales in 2011.

#### Service

Service revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $8.1 million, or 11.2% of revenue, for the three months ended September 30, 2011, compared with $8.9 million, or 11.9% of revenue, for the three months ended September 30, 2010. Service revenue was $23.7 million, or 9.2% of revenue for the nine months ended September 30, 2011, compared with $24.7 million, or 13.6% of revenue for the nine months ended September 30, 2010. Service revenue is affected by the expansion of the installed base of off-warranty systems and can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities.

#### Ion Implant

Included in total revenue of $72.5 million for the three month period ended September 30, 2011, is revenue from sales of ion implantation products and service of $51.1 million, or 70.5% of total revenue, compared with $64.2 million, or 85.5% of total revenue, for the three months ended September 30, 2010. The dollar decrease was due to the factors discussed above for product revenue. Revenue from sales of ion implantation products and service accounted for $187.8 million, or 72.5% of revenue, for the nine months ended September 30, 2011, compared to $153.2 million, or 84.3% of revenue, in the nine months ended September 30, 2010. The dollar increase was due to the factors discussed above for product revenue.

#### Aftermarket

The Company’s product revenues include sales of spare parts and product upgrades as well as complete systems. We refer to the business of selling spare parts and product upgrades, combined with the sale of maintenance labor and service contracts and service hours, as the “aftermarket” business. Included in total revenue of $72.5 million is revenue from our aftermarket business of $37.3 million for the three months ended September 30, 2011, compared to $36.0 million for the three months ended September 30, 2010. The revenue from our aftermarket business was $115.4 million for the nine months ended September 30, 2011, compared to $104.5 million for the nine months ended September 30, 2010. Aftermarket revenue generally increases with expansion of the installed base of systems but can fluctuate period to period based on capacity utilization at customers’ manufacturing facilities, which affects the sale of spare parts and demand for equipment service.

### Gross Profit

#### Product

Gross profit from product revenue was 37.8% for the three months ended September 30, 2011, compared to gross profit of 27.7% for the three months ended September 30, 2010. The increase in gross profit of 10.1% is attributable to lower revenue deferrals and favorable absorption of fixed overhead costs which accounted for 7.9%, a higher mix of a parts and upgrade revenue which accounted for 1.8% and a lower provision for excess inventory which accounted for 0.4%. Gross profit from product revenue was 36.3% for the nine months ended September 30, 2011, compared with 28.8% for the nine months ended September 30, 2010. The increase in gross profit of 7.5% is attributable to higher systems sales volume and the related favorable absorption of fixed overhead costs which accounted for 16.0% and a lower provision for excess inventory which accounted for 0.5%, offset by a lower mix of parts and upgrade revenue at lower margins which reduced gross profit by 9.0%.

#### Service

Gross profit from service revenue was 32.1% for the three months ended September 30, 2011, compared to 35.3% for the three months ended September 30, 2010. Gross profit from service revenue was 28.1% for the nine months ended September 30, 2011, compared to 36.8% for the nine months ended September 30, 2010. The decrease in gross profit for the three and nine months ended September 30, 2011, is attributable to lower volumes, higher fixed service costs and changes in the mix and timing of service contracts.

### Research and Development

Research and development expense was $11.4 million in the three months ended September 30, 2011, an increase of $1.5 million, or 15.2%, compared with $9.9 million in the three months ended September 30, 2010. The increase was due to increased payroll costs ($0.6 million) due to increased headcount to support new product development activities, increased project materials and consultants expense ($0.4 million) and increased asset amortization and depreciation costs for assets used as demonstration and/or test systems ($0.5 million). Research and development expense was $35.0 million for the nine months ended September 30, 2011, an increase of $6.5 million or 22.8%, compared with $28.5 million for the nine months ended September 30, 2010. The increase was comprised of increased payroll costs ($3.1 million), increased project materials and consultants expense ($2.4 million), and increased development asset amortization and depreciation costs ($1.0 million), substantially all of which are attributable to new product development activities.

### Sales and Marketing

Sales and marketing expense was $7.2 million for the three months ended September 30, 2011, equal to the spending in the three months ended September 30, 2010. Sales and marketing expense was $22.7 million for the nine months ended September 30, 2011, an increase of $2.3 million, or 11.3%, compared with $20.4 million for the nine months ended September 30, 2011. The increase was primarily due to increased payroll costs ($2.1 million) due to the increased sales volume of our products experienced by the Company during the year, increased commission costs ($0.8 million), increased travel costs of ($0.3 million), increased freight costs ($0.5 million), and decreased supplies and marketing services expense ($1.4 million).

### General and Administrative

General and administrative expense was $8.5 million for the three months ended September 30, 2011, an increase of $0.6 million or 7.6%, compared with $7.9 million in the three months ended September 30, 2010. The increase was due to increased compensation expense due to increased incentive compensation accruals and higher headcount ($1.0 million) and decreased professional services ($0.4 million). General and administrative expense was $25.9 million for the nine months ended September 30, 2011, an increase of $2.9 million, or 12.6%, compared with $23.0 million in the nine months ended September 30, 2010. The increase was due to increased compensation expense due to increased incentive compensation expense and higher headcount ($3.0 million) and separation costs associated with the retirement of a former executive of the Company ($0.3 million) and decreased professional services ($0.4 million).

### Other Income (Expense)

Other income was $1.6 million for the three months ended September 30, 2011 compared with other expense of $2.0 million for the three months ended September 30, 2010. Other income (expense) for the three months ended September 30, 2011 primarily consisted of foreign exchange gains compared to foreign exchange losses in 2010, as a result of U.S. dollar currency fluctuations against the local currencies of certain of the countries in which we operate.

For the three and nine months ended September 30, 2011 the Company incurred $1.8 million and $0.7 million of foreign exchange gains. For the three and nine months ended September 30, 2010 the Company incurred $1.5 million and $0.9 million of foreign exchange losses.

### Income Taxes

We incur income tax expense relating principally to operating results of foreign entities in Europe and Asia, where we earn taxable income. We have significant net operating loss carryforwards in the United States and certain European tax jurisdictions, and, as a result, we do not currently pay significant income taxes in those jurisdictions. Additionally, we do not recognize the tax benefit for losses in the United States and certain European tax jurisdictions. Accordingly, our effective income tax rate is not meaningful.

### Liquidity and Capital Resources

We believe that based on our current market, revenue and expense forecasts, our existing cash and cash equivalents, and available credit will be sufficient to satisfy our anticipated cash requirements for the foreseeable future. The Company is also exploring a sale - leaseback transaction of our Beverly, MA facility which would further strengthen our cash position. Our liquidity is affected by many factors. Some of these relate specifically to the operations of our business, for example, the rate of acceptance of our Optima and Integra product lines, and others relate to the uncertainties of global economies, including the availability of credit and the condition of the overall semiconductor equipment industry.

During the nine months ended September 30, 2011, $0.9 million of cash was generated to support operating activities, including increased levels of inventories in anticipation of future system sales. Cash and cash equivalents at September 30, 2011 were $44.4 million, compared to $45.7 million at December 31, 2010. In the event that demand for Axcelis’ products declines in future periods, the Company believes it can align manufacturing and operating spending levels to the changing business conditions and provide sufficient liquidity to support operations.

On April 25, 2011, the Company amended its existing revolving credit facility with a bank. The amended agreement provides for borrowings up to $30 million based primarily on accounts receivable. The facility has certain financial covenants requiring us to maintain minimum levels of operating results and liquidity. The agreement will terminate on April 10, 2015. The Company uses the facility to support letters of credit and hedging transactions.

At September 30, 2011 the Company’s available borrowing capacity under the amended credit facility was $24.9 million and the Company was compliant with all covenants of the loan agreement.

### Commitments and Contingencies

Significant commitments and contingencies at September 30, 2011 are consistent with those discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 16 to the consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010.

## Market risk

As filed, 191 characters.

As of September 30, 2011, there have been no material changes to the information about market risk disclosed in Item 7A to our annual report on Form 10-K for the year ended December 31, 2010.

## Controls and procedures

As filed, 1,021 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, these disclosure controls and procedures are effective.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during the third quarter of 2011 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 174 characters.

As of September 30, 2011, there have been no material changes to the risk factors described in Item 1A to our annual report on Form 10-K for the year ended December 31, 2010.

Filed Nov 4, 2011.
Source: SEC EDGAR, the filing index for accession 0001104659-11-061003. Last ingested by Listed: Nov 13, 2026, 17:24 ET. No prices; not investment advice.
